The Molecular Landscape of Placental Dysfunction in Fetal Growth Restriction (FGR): From Integrated Signaling Networks to Epigenetic Control
Biology · 09.11.2026 · 15 (21) · 2046
DOI: 10.3390/biology15212046 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biology, online erschienen am 09.11.2026. Verfasst von Fani-Niki Varra und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, School of Health Sciences, Frederick University, Nicosia 1036, Cyprus. Die Arbeit nennt 183 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Fetal growth restriction (FGR) is a major pregnancy complication linked to placental insufficiency, resulting from defective trophoblast differentiation, impaired maternal–fetal vascular adaptation, and altered nutrient sensing. This review synthesizes current evidence on the interconnected molecular networks driving placental dysfunction. We map the reciprocal crosstalk between the pro-inflammatory shift, highlighted by NLRP3 inflammasome-driven trophoblast pyroptosis, and dysregulated extracellular matrix remodeling mediated by the MMP-9/TIMP system. This hostile microenvironment feeds directly into the angiogenic imbalance defined by the sFlt-1/PlGF ratio, accelerating cellular senescence via p53 and disrupting survival hubs like the PTEN/PI3K/AKT axis. Consequently, downstream metabolic sensors, notably the mTOR pathway, are blunted, causing trafficking failure of essential amino acid (SNAT2, LAT1) and glucose (GLUT) transporters. Crucially, we introduce an original framework integrating emerging spatial transcriptomics and single-cell epigenomics, demonstrating that these pathomechanisms are anatomically regionalized rather than uniform. Finally, we provide a critical evaluation of translation-ready therapeutic targets, emphasizing that strict safety constraints against fetal teratogenesis render ligand-functionalized nanoparticles a non-negotiable prerequisite for placenta-selective drug delivery. Integrating molecular stratification with longitudinal biomarker profiling represents the next milestone for mechanism-based, targeted management of FGR.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, School of Health Sciences, Frederick University, Nicosia 1036, Cyprus.
- Medical School, Democritus University of Thrace, 6810 Alexandroupolis, Greece.
- Department of Physiology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
- Fourth Department of Obstetrics and Gynecology, 'Elena Venizelou' General and Maternity Hospital, 11521 Athens, Greece.
- Department of Pharmacy, School of Health Sciences, University of Patras, University Campus, 26504 Patra, Greece.
- First Department of Pathology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
ORCID-Profile: Anastassios Philippou
Zitieren
APA
Varra, F. N., Varras, M., Varra, V. K., Theodosis-Nobelos, P., Stefanidis, K., & Philippou, A. (2026). The Molecular Landscape of Placental Dysfunction in Fetal Growth Restriction (FGR): From Integrated Signaling Networks to Epigenetic Control. Biology, 15(21), 2046. https://doi.org/10.3390/biology15212046
Vancouver
Varra FN, Varras M, Varra VK, Theodosis-Nobelos P, Stefanidis K, Philippou A. The Molecular Landscape of Placental Dysfunction in Fetal Growth Restriction (FGR): From Integrated Signaling Networks to Epigenetic Control. Biology. 2026;15(21):2046. doi:10.3390/biology15212046
BibTeX
@article{Varra2026,
author = {Varra, Fani-Niki and Varras, Michail and Varra, Viktoria-Konstantina and Theodosis-Nobelos, Panagiotis and Stefanidis, Konstantinos and Philippou, Anastassios},
title = {The Molecular Landscape of Placental Dysfunction in Fetal Growth Restriction (FGR): From Integrated Signaling Networks to Epigenetic Control},
journal = {Biology},
year = {2026},
volume = {15},
number = {21},
pages = {2046},
doi = {10.3390/biology15212046}
}
EUVIMED